SPOTLIGHT: FDA wants more Arixtra info


The FDA has asked for more information from GlaxoSmithKline regarding its application to use the anti-clotting drug Arixtra for unstable angina. GSK didn't elaborate on what the agency was looking for, but said it would cooperate. Release | Report